Newsletter | December 8, 2023

12.08.23 -- Will Funding And Financing Rebound Next Year?

SPONSOR

Join The Advancing RNA Community

Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like Analytical/Quality, Manufacturing, Formulation, Outsourcing, Clinical Research, and Supply Chain/Logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly.

FEATURED ARTICLES

Finance And Funding: Anticipating Improvement, Planning For Uncertainty

Executives responding to this year’s finance and funding outlook questions are optimistic about the potential for a turnaround in 2024.

Top 10 Reasons For Oral Dose CMO Preference

Just under one-third of respondents who participated in ISR’s Oral Dosage Forms Market Outlook research shared that familiarity/history of working together/prior positive experience are the reasons behind their preferences.

You Can Increase Your Odds Of Hiring And Retaining The Best Talent

Finding scientific talent is an arduous process, often stealing precious time from our calendars. Furthermore, hiring well doesn’t have to be left to chance. Try these specific actions.

INDUSTRY INSIGHTS

5 Reasons To Switch To Multicolumn Chromatography

See for yourself how multicolumn chromatography technologies can transform your existing batch processes and provide a first step in your exploration of continuous processing.

Biofidelity Introduces Novel Lung Cancer Assay For Precision Medicine

We discuss the launch of a rapid and cost-effective biomarker assay to guide non-small cell lung cancer treatment decisions in the U.S., addressing the need for quicker and more informed precision medicine.

Early Plasmid Optimization For Long-Term Commercial Success

Securing the right plasmid for an application can be a complex endeavor. Core to this is selecting a supplier with the quality assurance protocols and GMPs to facilitate optimized plasmid production.

Rapid Characterization Of Impurities

Understand how to manage impurities in drug development with swift isolation, synthesis, and analysis. A client discovered an impurity that exceeded ICH guidelines during ongoing stability studies.

DIGITAL EDITION

December 2023 Digital Edition

Inside you will find more on:

  • Supply Chain Outlook
  • Next-Gen RNA Therapeutics
  • Moving Beyond AAV
  • Biopharma Reputation Challenge

View the digital edition.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: